PriceTargets.com logo

Theratechnologies - TH Stock Price Target and Predictions

  • Consensus Rating: Strong Buy
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 2 Strong Buy Ratings
C$3.86 As of 05/2/2025 04:59 PM ET
▼ -0.18 (-4.46%)

This chart shows the closing price for TH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
MarAprC$3.86Closing price on 05/03/25:
Get New Theratechnologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TH

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Theratechnologies in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$3.86.

This chart shows the closing price for TH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
5/247/2410/241/255/255/26C$1.12C$1.95C$2.78C$3.61C$4.44Closing price on 05/03/25: C$3.86HighC$0.0000AverageC$0.0000LowC$10.00M




Current Consensus is Strong Buy

The current consensus among 2 contributing investment analysts is to buy (strong buy) stock in Theratechnologies. This rating has held steady since January 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/11/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/4/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2025

Latest Recommendations

  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/11/2025Jones TradingUpgradeHold ➝ Strong-Buy
2/14/2025Research CapitlUpgradeStrong-Buy
1/12/2024Cantor FitzgeraldReiterated RatingOverweight
9/27/2023National BanksharesLower TargetSector PerformC$7.00 ➝ C$5.50
8/1/2023National BanksharesBoost TargetSector PerformC$1.75 ➝ C$7.00
7/13/2023National BanksharesLower TargetC$2.25 ➝ C$1.75
4/13/2023National BanksharesLower TargetSector PerformC$3.25 ➝ C$2.25
1/5/2023Leede Jones GabUpgradeHold ➝ Speculative Buy
11/17/2022Cantor FitzgeraldReiterated RatingOverweight
7/15/2022National BanksharesLower TargetSector PerformC$3.75 ➝ C$3.25
10/14/2021National BanksharesReiterated RatingHoldC$3.75
2/26/2021Leede Jones GabDowngradeSpeculative Buy ➝ Hold
1/20/2021National Bank FinancialReiterated RatingSector PerformC$3.75
7/15/2020National Bank FinancialReiterated RatingSector Perform Market Weight
(Data available from 5/4/2020 forward)

News Sentiment Rating

0.33 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/4/2025
  • 2 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/3/2025
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/5/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/4/2025
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2025

Current Sentiment

  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Theratechnologies logo
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Read More

Today's Range

Now: C$3.86
Low: C$3.82
High: C$4.10

50 Day Range

MA: C$2.70
Low: C$1.85
High: C$4.04

52 Week Range

Now: C$3.86
Low: C$1.59
High: C$4.33

Volume

103,578 shs

Average Volume

109,030 shs

Market Capitalization

C$123.16 million

P/E Ratio

N/A

Dividend Yield

3.76%

Beta

1.73

Frequently Asked Questions

What sell-side analysts currently cover shares of Theratechnologies?

The following equities research analysts have issued research reports on Theratechnologies in the last year: Jones Trading, and Research Capitl.
View the latest analyst ratings for TH.

What is the current price target for Theratechnologies?

0 Wall Street analysts have set twelve-month price targets for Theratechnologies in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Theratechnologies in the next year.
View the latest price targets for TH.

What is the current consensus analyst rating for Theratechnologies?

Theratechnologies currently has 2 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Strong Buy."
View the latest ratings for TH.

What other companies compete with Theratechnologies?

Other companies that are similar to Theratechnologies include CENTRIC HEALTH, Maple Gold Mines, Mount Logan Capital, Jaxon Mining and Pacific Paradym Energy. Learn More about companies similar to Theratechnologies.

How do I contact Theratechnologies' investor relations team?

Theratechnologies' physical mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company's listed phone number is +1-514-3367800. The official website for Theratechnologies is www.theratech.com. Learn More about contacing Theratechnologies investor relations.